Phathom Pharmaceuticals Overview
Phathom Pharmaceuticals Discounted Cash Flow
DCF Analysis for PHAT.
Get informed when a big investor buys or sells
+ FollowFair Value
$-4.09
Current Fair Value
$-4.09
↓ 138.2% Downside
Overvalued by 138.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison